Like coronavirus, Hepatitis C was only discovered as unique a few decades ago, but in that time science took its 2 million new HCV infections every year, with an estimated 70 million carriers of the virus globally, and 400,000 deaths annually to finding a cure.
Directly acting antivirals (DAAs) can now stop it and therefore prevent the liver cirrhosis and liver cancer that can develop. Next up,
said Professor Sir Michael Houghton at the European Society of Clinical Microbiology and Infectious Diseases, who won the Nobel Prize for Medicine and Physiology along with three other scientists for discovering it was distinct in 1989, is a vaccine.